Unique ID issued by UMIN | UMIN000005029 |
---|---|
Receipt number | R000005941 |
Scientific Title | Evaluation of the usefulness of breast CT imaging in delineating tumor extent and guiding surgical management: a prospective multi-institutional study |
Date of disclosure of the study information | 2011/02/07 |
Last modified on | 2011/02/04 08:56:46 |
Evaluation of the usefulness of breast CT imaging in delineating tumor extent and guiding surgical management: a prospective multi-institutional study
Evaluation of the usefulness of breast CT imaging in delineating tumor extent and guiding surgical management: a prospective multi-institutional study
Evaluation of the usefulness of breast CT imaging in delineating tumor extent and guiding surgical management: a prospective multi-institutional study
Evaluation of the usefulness of breast CT imaging in delineating tumor extent and guiding surgical management: a prospective multi-institutional study
Japan |
breast cancer
Breast surgery |
Malignancy
NO
to evaluate the usefulness of CT imaging in addition to mammography, ultrasonography and palpation, in delineating tumor extent and guiding surgical management
Efficacy
Confirmatory
Pragmatic
Not applicable
The rate at which CT findings modified the planned surgical procedure, and whether or not it was effective.
1) If the newly identified region by CT included tumor in the pathological examination, the alteration was judged as effective.
2) If pathological examination revealed no tumor in the newly identified region, the alteration was evaluated as ineffective.
false negative detection
false positive detection
Interventional
Single arm
Non-randomized
Open -but assessor(s) are blinded
Uncontrolled
1
Treatment
Device,equipment |
performing breast CT preoperatively
Not applicable |
Not applicable |
Female
1) Patients with histologically proven breast cancer, who were candidates for BCS as determined by palpation, MMG and US.
2) Patients without microcalcifications or with microcalcifications at most 2 cm away from the tumor).
3) Patients who provided written informed consent.
1) Patients who have allergy to iodine containing contrast medium.
2) Patients who received neoadjuvant chemotherapy or endocrine therapy.
300
1st name | |
Middle name | |
Last name | Futoshi Akiyama |
Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
Division of Pathology
Ariake 3-8-31 Koto-ku, Tokyo
03-3520-0111
1st name | |
Middle name | |
Last name | Sadako Akashi-Tanaka |
National Cancer Center Hospital, Tokyo, Japan
Breast Surgery Division
Tsukiji 5-1-1 Chuo-ku, Tokyo
03-3542-2511
sakashi@ncc.go.jp
Grants for Scientific Research from the Expenses for Health and Welfare Program (17-7) from the Ministry of Health, Labour and Welfare of Japan
Grants for Scientific Research from the Expenses for Health and Welfare Program (17-7) from the Ministry of Health, Labour and Welfare of Japan
Japan
NO
国立がん研究センター病院(東京)、新潟県立がんセンター新潟病院(新潟県)、四国がんセンター(愛媛県)、大阪成人病センター(大阪府)、北福島医療センター(福島県)、呉医療センター中国がんセンター(広島県)
2011 | Year | 02 | Month | 07 | Day |
Partially published
Completed
2005 | Year | 12 | Month | 13 | Day |
2006 | Year | 04 | Month | 01 | Day |
2008 | Year | 08 | Month | 01 | Day |
2008 | Year | 08 | Month | 01 | Day |
2009 | Year | 06 | Month | 01 | Day |
2011 | Year | 02 | Month | 05 | Day |
2011 | Year | 02 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005941
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |